Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis I
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
A. Ongel, N. Bakirci, H. Arda, G. Cetintas, S. Bilgin Kiziltas, K. Oruc, S. Agca, H. C. Calisir (Maltepe/Istanbul, Istanbul, Turkey). Risk factors of hepatotoxicity during tuberculosis treatment and management. Eur Respir J 2008; 32: Suppl. 52, 2435

Member's Comments

No comment yet.

Related content which might interest you: Risk factors for relapses of tuberculosis Source: Eur Respir J 2003; 22: Suppl. 45, 345s Year: 2003 Risk factors for anti-tuberculosis treatment failure Source: Annual Congress 2011 - Tuberculosis epidemiology and public health Year: 2011 Risk factors for paradoxical response during adequate tuberculosis treatment Source: Eur Respir J 2005; 26: Suppl. 49, 649s Year: 2005 Risk factors for extrapulmonar tuberculosis Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings Year: 2012 Risk factors for tuberculosis in patients with chronic alcoholism Source: Virtual Congress 2021 – Epidemiological aspects of tuberculosis Year: 2021 Diseases and their treatment as risk factors for tuberculosis Source: Annual Congress 2004 - Risks for tuberculosis Year: 2004 Risk Factors for tuberculosis in patients on anti-TNF treatment Source: International Congress 2019 – Tuberculosis and comorbidities Year: 2019 Chemotherapy and tuberculosis as risk factors of urolithiasis Source: Eur Respir J 2005; 26: Suppl. 49, 688s Year: 2005 Risk factors in tuberculosis and its influence on chemotherapy efficiency Source: Eur Respir J 2005; 26: Suppl. 49, 649s Year: 2005 The assessment of risk factors and treatment of pulmonary TB relapses Source: Eur Respir J 2006; 28: Suppl. 50, 129s Year: 2006 Antituberculosis drug-induced hepatotoxicity: influence on the management and outcome of active tuberculosis (TB) Source: Annual Congress 2007 - Epidemiology of tuberculosis II Year: 2007 Treatment interruptions in patients with MDR/XDR-TB: risk factors and impact on treatment outcomes Source: International Congress 2016 – Drug-resistant tuberculosis and experiences with delamanid and bedaquiline Year: 2016 Risk factors for asthma and their prevention Source: Annual Congress 2008 - PG2 - Asthma: natural history, risk factors and overall management Year: 2008 Risk factors for fatal tuberculosis among immunocompetent patients. Source: International Congress 2017 – TB: co-morbidities and outcome Year: 2017 Risk factors for tuberculosis relapse in Polish patients Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013 Pulmonary tuberculosis relapse: predisposing factors and management in Tunisia Source: Annual Congress 2007 - Medical and surgical treatment of susceptible and resistant tuberculosis Year: 2007 Risk factors for the misdiagnosis of tuberculosis in the UK, 2001–2011 Source: Eur Respir J 2015; 46: 564-567 Year: 2015 Survival and risk factors of mortality among defaulters from treatment of pulmonary tuberculosis Source: Annual Congress 2012 - MDR- and XDR-TB: epidemiological and public health overview Year: 2012 Risk factors associated with death in pulmonary tuberculosis Source: Annual Congress 2009 - Socio-economic impact of tuberculosis Year: 2009 Risk of tuberculosis in pediatric patients treated with biological agents Source: Virtual Congress 2020 – Aspects of acute and chronic airway infections in children Year: 2020